Healthcare -
Biotechnology - NASDAQ - US
$ 22.04
-0.136 %
$ 3.74 B
Market Cap
-9.97
P/E
IMVT - TOTAL ASSETS
Total Assets IMVT - Immunovant, Inc.
666 M
LAST VALUE
13.69%
2 YEAR CAGR
339.80%
5 YEAR CAGR
0.00%
10 YEAR CAGR